ELOVL5 and breast carcinoma: Consistent with these insights, Tonevitsky et al. identified that low expression levels of ELOVL5 in breast cancer is correlated with poor prognosis because ELOVL5 can produce PUFAs that can induce ferroptosis in cancer cells [100].